Explore more publications!

Penn STEM Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Penn STEM Times.

Press releases published on December 15, 2025

HMP Global’s Symposium on Advanced Wound Care (SAWC) Announces 2026 Partnership with NPIAP
Appluent Business Solutions Announces Official HubSpot Partnership, Expanding Hybrid CRM Capabilities for Customers
New RentRedi Survey Shows Landlords Worried About Missed/Late Rent Payments, While Tenants Point to the Tools That Help Them Pay On Time
Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
CLEAR Launches CLEAR ID: A New, Free Way to Present Your ID at TSA Checkpoints with the CLEAR Mobile App
Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations, a Serious, Rare Genetic Disease with No…
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01
VivoPower Announces Update to Annual General Meeting
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
NANOBIOTIX va intégrer les indices CAC Mid 60 et SBF 120 d’Euronext Paris
Denodo wird zum sechsten Mal in Folge als führendes Unternehmen im Gartner® Magic Quadrant™ für Datenintegrationstools 2025 ausgezeichnet
Denodo désigné comme leader du Magic Quadrant™ 2025 de Gartner® pour les outils d’intégration de données pour la sixième année consécutive
Syncron Expands Global Value-Added Reseller Program with Tridant Partnership in Australia and New Zealand
Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la sclérose en plaques primaire progressive
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolébrutinib dans la sclérose en plaques secondaire progressive non-récurrente
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Denodo נבחרה כמובילה ב-2025 Gartner® Magic Quadrant™ לכלי שילוב נתונים זו השנה השישית ברציפות
Denodo Dinamakan sebagai Peneraju dalam Gartner® Magic Quadrant™ 2025 bagi Alat Integrasi Data untuk Enam Tahun Berturut-turut

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions